GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » PS Ratio

Perspective Therapeutics (FRA:AAJ) PS Ratio : (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Perspective Therapeutics's share price is €1.35. Perspective Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.01. Hence, Perspective Therapeutics's PS Ratio for today is .

The historical rank and industry rank for Perspective Therapeutics's PS Ratio or its related term are showing as below:

During the past 13 years, Perspective Therapeutics's highest PS Ratio was 28.73. The lowest was 2.51. And the median was 6.31.

FRA:AAJ's PS Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.28
* Ranked among companies with meaningful PS Ratio only.

Perspective Therapeutics's Revenue per Sharefor the three months ended in Mar. 2024 was €0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Perspective Therapeutics was -116.30% per year.

During the past 13 years, Perspective Therapeutics's highest 3-Year average Revenue per Share Growth Rate was 18.00% per year. The lowest was -22.00% per year. And the median was -9.85% per year.

Back to Basics: PS Ratio


Perspective Therapeutics PS Ratio Historical Data

The historical data trend for Perspective Therapeutics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics PS Ratio Chart

Perspective Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 3.88 8.23 4.07 -

Perspective Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.84 22.27 10.95 - -

Competitive Comparison of Perspective Therapeutics's PS Ratio

For the Medical Devices subindustry, Perspective Therapeutics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perspective Therapeutics's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's PS Ratio falls into.



Perspective Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Perspective Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.35/-0.006
=

Perspective Therapeutics's Share Price of today is €1.35.
Perspective Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Perspective Therapeutics  (FRA:AAJ) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Perspective Therapeutics PS Ratio Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perspective Therapeutics (FRA:AAJ) Business Description

Traded in Other Exchanges
Address
350 Hills Street, Suite 106, Richland, WA, USA, 99354
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines